Valiant Organics Limited — Important, 01-07-2025: General Updates

Valiant Organics has announced a board meeting to discuss the financial results for the quarter and half-year. The company remains a leading global manufacturer of chlorophenol derivatives with a total production capacity of 70,000 MTPA across six manufacturing units. FY25 revenue stood at INR 7,188 Mn, with EBITDA margins improving slightly to 7.47%. Challenges persist with profitability, showing a net loss of INR 34 Mn. Ongoing capex includes ramping up Ortho Amino Phenol production to reduce import dependence. Strong client relationships and raw material security underpin their specialty chemical portfolio focused on export-driven growth.